Antibacterial composition and application thereof
By using antibacterial compositions of cypress alcohol and a variety of plant extracts, the problems of single antibacterial effect and difficulty in quality control in the prior art are solved, and broad-spectrum antibacterial and stable therapeutic effects on a variety of microorganisms are achieved, and it is suitable for multiple microorganisms. A kind of infection situation.
Patent Information
- Application Number
- CN202410994424.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-24
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-07-24
AI Technical Summary
The existing plant-source antibacterial composition has a single antibacterial effect and cannot effectively cover a variety of microorganisms and drug-resistant microorganisms. Moreover, due to the unclear antibacterial active ingredients, it is difficult to control quality, which affects the stable therapeutic effect of the product.
Using antibacterial compositions including cypress alcohol, mulberry white bark extract, cypress extract, hosta root extract and tik palm grass extract, the broad-spectrum antibacteriality of the composition is ensured by optimizing the extraction method and purification process. and stability.
Provides effective inhibitory effects on Gram-positive bacteria, Gram-negative bacteria and fungi, including antibiotic-resistant bacteria, reduces the amount of extract, reduces product costs, and ensures antibacterial effect by controlling the content of active ingredients. Stability, suitable for a variety of infection conditions.
Smart Images

Figure CN119033875A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of biomedicine, and specifically relates to an antibacterial composition and application thereof. Background Art
[0002] Bacterial infections pose a constant threat to human health. Since the discovery of penicillin, various antibiotics have been widely used to treat bacterial infections. However, with the widespread use of antimicrobial drugs, the problem of bacterial resistance has become increasingly serious. The World Health Organization pointed out that drug-resistant bacteria have become a major challenge in the current public health field. It is difficult to solve this problem by relying solely on existing antibiotics and other means, and there is an urgent need to find new green antibiotics.
[0003] Natural antimicrobial agents from plants have the characteristics of good antimicrobial activity, safety, high efficiency, and abundant resources, and can be used as substitutes for traditional antimicrobial agents. However, in the prior art, traditional plant-derived antimicrobial compositions have some limitations. For example, their antimicrobial effects are usually relatively single and cannot effectively cover a variety of microorganisms and drug-resistant microorganisms. In addition, due to the unclear antimicrobial and antimicrobial active ingredients, it is difficult to conduct effective quality control, which may affect the stable efficacy of the product. Summary of the invention
[0004] The object of the present invention is to provide an antibacterial composition having a broad-spectrum antibacterial property and a stable antibacterial effect.
[0005] The present invention provides an antibacterial composition, which comprises a first component, a second component and a third component;
[0006] The first component includes hinokitiol; the second component includes mulberry bark extract and / or cloud hemp extract; the third component includes hosta root extract and / or tiger palm extract.
[0007] Preferably, in the antibacterial composition, the concentration of the first component is ≥32 μg / mL; the concentration of the second component is ≥4 μg / mL; the concentration of the third component is ≥16 μg / mL;
[0008] Preferably, calculated on a dry product basis, the total amount of mulberry extract, mulberry flavonoids G and mulberry ketone H in the mulberry bark extract is 10 wt% to 60 wt%;
[0009] In the hemp extract, the total amount of cannabidiol and cannabidiol is 10wt% to 60wt%;
[0010] In the hosta root extract, the total amount of (25R)-2α,3β-dihydroxy-5α-spirostan-9-ene-12-one-3-O-β-D-pyranoglucopyranosyl-(1→2)-[β-D-pyranoxylanosyl-(1→3)]-β-D-pyranoglucopyranosyl-(1→4)-β-D-galactopyranoside is 1wt% to 10wt%;
[0011] In the Herba Lycopodii extract, the content of prosapogenin CP4 is 20wt% to 80wt%.
[0012] Preferably, the preparation method of the mulberry bark extract comprises: mixing mulberry bark powder with 80% to 95% v / v ethanol solution, soaking for 12 to 24 hours, heating and refluxing extraction at 80 to 90° C. for 2 to 5 times, each time for 3 to 5 hours, combining the extracts, filtering under reduced pressure, concentrating, and drying to constant weight to obtain a crude mulberry bark extract; purifying the crude extract to obtain a mulberry bark extract;
[0013] The preparation method of the cloud hemp extract comprises: mixing cloud hemp powder with 80% to 95% v / v ethanol solution, soaking for 12 to 24 hours, heating and refluxing extraction at 80 to 90° C. for 2 to 5 times, each time for 3 to 5 hours, combining the extracts, filtering under reduced pressure, concentrating, and drying to constant weight to obtain a cloud hemp crude extract; purifying the cloud hemp crude extract to obtain the cloud hemp extract;
[0014] The preparation method of the hosta root extract comprises: mixing the hosta root powder with 80% to 95% v / v ethanol solution, soaking for 12 to 24 hours, heating and refluxing extraction at 80 to 90° C. for 2 to 5 times, each time for 3 to 5 hours, combining the extracts, filtering under reduced pressure, concentrating, and drying to constant weight to obtain a crude hosta root extract; purifying the crude hosta extract to obtain the hosta root extract;
[0015] The preparation method of the tiger palm grass extract comprises: mixing tiger palm grass powder with 80% to 95% v / v ethanol solution, soaking for 12 to 24 hours, heating and refluxing extraction at 80 to 90° C. for 2 to 5 times, each time for 3 to 5 hours, combining the extracts, filtering under reduced pressure, concentrating, and drying to constant weight to obtain a crude tiger palm grass extract; adding water to re-dissolve the crude tiger palm grass extract, filtering, precipitating with hot acetone, and filtering again to obtain the tiger palm grass extract;
[0016] The solid-liquid ratio of the mulberry bark powder to the 80%-95% v / v ethanol solution is 40-60 g / L; the solid-liquid ratio of the cloud hemp powder to the 80%-95% v / v ethanol solution is 40-60 g / L; the solid-liquid ratio of the hosta root powder to the 80%-95% v / v ethanol solution is 40-60 g / L; the solid-liquid ratio of the tiger palm powder to the 80%-95% v / v ethanol solution is 40-60 g / L.
[0017] Preferably, the purification comprises purification using a macroporous resin.
[0018] The present invention also provides the use of the antibacterial composition described in the above technical solution in the preparation of antibacterial products.
[0019] Preferably, the antibacterial product includes a product that inhibits the activity of pathogenic bacteria; the pathogenic bacteria include bacteria and / or fungi, and the bacteria and / or fungi include antibiotic-resistant bacteria and / or fungi.
[0020] Preferably, the dosage form of the product includes one or more of paste, cream, emulsion, gel, spray, aqueous solution, lotion, soap, ointment, suppository, capsule, powder, granule, tablet and effervescent.
[0021] The present invention also provides an antibacterial cream, which comprises the following ingredients: 0.02wt%-1wt% of the antibacterial composition described in the above technical scheme, 10wt%-30wt% of glycerol, 4wt%-10wt% of beeswax, 4wt%-10wt% of liquid paraffin, 1wt%-10wt% of octadecyl alcohol, 0.5wt%-5wt% of hexadecanol, 1wt%-10wt% of white vaseline, 1wt%-8wt% of silicone oil, 0.2%wt-5wt% of glyceryl monostearate, 1wt%-6wt% of propylene glycol, 0.1wt%-2wt% of Tween 80, 0.1wt%-1wt% of triethanolamine, and the remainder of water and polyoxyethylene hydrogenated castor oil; the mass ratio of the polyoxyethylene hydrogenated castor oil to the antibacterial composition is 0.5-3:1.
[0022] The present invention also provides an antibacterial cream, which comprises the following ingredients: 0.02wt%-1wt% of the antibacterial composition described in the above technical solution, 60wt%-80wt% of white vaseline, 5wt%-20wt% of glycerol, 1wt%-10wt% of lanolin, 0.5wt%-5wt% of liquid paraffin, 0.2wt%-5wt% of glyceryl monostearate, 1wt%-6wt% of propylene glycol, 0.1wt%-2wt% of Tween 80, 0.0wt%-0.5wt% of borneol, and the remainder of water and polyoxyethylene hydrogenated castor oil; the mass ratio of the polyoxyethylene hydrogenated castor oil to the antibacterial composition is 0.5-3:1.
[0023] Beneficial effects:
[0024] The antibacterial composition provided by the present invention has an effective inhibitory effect on Gram-positive bacteria, Gram-negative bacteria and fungi, especially antibiotic-resistant bacteria; and some compositions have a synergistic effect, which can reduce the amount of extracts used, thereby reducing product costs. The antibacterial composition provided by the present invention is derived from widely available plant raw materials, has a simple preparation process, low cost, and is market-friendly.
[0025] Furthermore, the present invention clarifies the active ingredients and their contents in different extracts. These active ingredients can be used as quality markers for quality control of each extract to ensure the stability of the antibacterial effect of the composition.
[0026] The antibacterial composition provided by the present invention has a wide range of applications and can be made into a variety of dosage forms such as pastes, emulsions, gels, sprays, and aqueous solutions. The application fields include improving fungal or bacterial infections of the skin, mucous membranes, and body surfaces, as well as antibacterial activity against antibiotic-resistant bacteria, covering a variety of infections such as trauma, surgical trauma, reproductive tract, external genitalia, oral cavity, hands and feet, etc. Specific application areas include prevention and treatment of carbuncle, dermatitis, eczema, psoriasis, rosacea, athlete's foot, onychomycosis, bedsores, burns, scalds, sunburn, trauma, mosquito bites, skin redness and swelling, stomatitis, vaginitis, and similar diseases of animal skin and mucous membranes. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required to be used in the embodiments are briefly introduced below.
[0028] Figure 1 A flow chart of the preparation of the antibacterial composition provided by the present invention;
[0029] Figure 2 The structural formula diagrams of the antibacterial activity markers in each extract;
[0030] Figure 3 is the LC-MS total ion chromatogram of each extract;
[0031] Figure 4 The antibacterial curves of each extract are shown in Figure 2.
[0032] Figure 5 is the antibacterial curve of hinokitiol;
[0033] Figure 6 It is the antibacterial curve diagram of composition 1 and composition 2;
[0034] Figure 7 The antibacterial curves of composition 3 and composition 4 are shown;
[0035] Figure 8 is the antibacterial curve diagram of composition 5;
[0036] Fig. 9 is the antibacterial curve diagram of composition 6;
[0037] Fig.10 is the antibacterial curve diagram of composition 7;
[0038] Fig.11 This is the antibacterial curve of composition 8. DETAILED DESCRIPTION
[0039] The invention provides an antibacterial composition, comprising a first component, a second component and a third component; the first component comprises hinokitiol; the second component comprises mulberry bark extract and / or cloud hemp extract; the third component comprises hosta root extract and / or tiger palm extract.
[0040] In the present invention, the first component includes hinokitiol, and more preferably hinokitiol; the concentration of the first component is preferably ≥32 μg / mL, more preferably ≥128 μg / mL, and more preferably 1600 μg / mL. The hinokitiol of the present invention is a highly safe plant ingredient with good antibacterial activity and a significant inhibitory effect on Gram-negative bacteria. Its structure is as follows:
[0041]
[0042] In the present invention, the second component includes Morus alba extract and / or Hesperidium edulis extract, preferably Morus alba extract and Hesperidium edulis extract or Morus alba extract or Hesperidium edulis extract, more preferably Morus alba extract. The concentration of the second component of the present invention is preferably ≥4 μg / mL, more preferably ≥16 μg / mL, more preferably 800 μg / mL; the Morus alba extract and Hesperidium edulis extract in the second component can play an anti-Gram-positive bacteria role.
[0043] In the present invention, the third component includes a hosta root extract and / or a tiger palm grass extract, preferably a hosta root extract and a tiger palm grass extract or a hosta root extract or a tiger palm grass extract. The concentration of the third component of the present invention is preferably ≥16 μg / mL, more preferably ≥64 μg / mL, and more preferably 800 μg / mL; the hosta root extract and the tiger palm grass extract in the third component can effectively inhibit the activity of pathogenic fungi.
[0044] As a preferred embodiment of the present invention, the antibacterial composition comprises hinokitiol, mulberry bark extract and hosta root extract; as a preferred embodiment of the present invention, the antibacterial composition comprises hinokitiol, mulberry bark extract and tiger palm grass extract; as a preferred embodiment of the present invention, the antibacterial composition comprises hinokitiol, cloud hemp extract and hosta root extract; as a preferred embodiment of the present invention, the antibacterial composition comprises hinokitiol, cloud hemp extract and tiger palm grass extract.
[0045] The antibacterial composition provided by the present invention has a broad-spectrum and highly effective antibacterial effect and can effectively fight against Gram-positive bacteria, Gram-negative bacteria and fungi, including antibiotic-resistant bacteria.
[0046] It is verified by the examples that the antibacterial composition provided by the present invention has a synergistic effect. Specifically: the combination of mulberry bark extract and hosta root extract has a synergistic effect against methicillin-resistant Staphylococcus aureus (MRSA), and the hosta root extract can reduce the minimum inhibitory concentration (MIC) of mulberry bark extract, and even if hinokitiol is added, the synergistic effect still exists; the combination of mulberry bark extract and tiger palm grass extract has a synergistic effect against MRSA and vancomycin-resistant enterococci (VRE), and the tiger palm grass extract can reduce the MIC value of mulberry bark extract, and even if hinokitiol is added, the synergistic effect still exists; the combination of ramie extract and hosta root extract has no effect on the activity of MRSA, and shows an antagonistic effect on VRE, but hinokitiol has a synergistic effect on both MRSA and VRE when combined with ramie extract and hosta root extract; the combination of ramie extract and tiger palm grass extract shows an antagonistic effect against MRSA and VRE, but hinokitiol has a synergistic effect on MRSA and VRE when combined with ramie extract and tiger palm grass extract.
[0047] In the present invention, calculated on a dry basis, the total amount of morusin, morusin G and morusin H in the Morus alba extract is preferably 10 wt % to 60 wt %, more preferably 30 wt % to 60 wt %, and more preferably 60 wt %. The preparation method of the mulberry bark extract of the present invention preferably comprises: mixing mulberry bark powder with 80%-95% v / v ethanol solution, soaking for 12-24 hours, heating and refluxing extraction at 80-90°C for 2-5 times, each time for 3-5 hours, combining the extracts, decompressing and filtering, concentrating, and drying to constant weight to obtain a mulberry bark crude extract; purifying the crude extract to obtain the mulberry bark extract; the solid-liquid ratio of the mulberry bark powder to ethanol is preferably 40-60 g / L, more preferably 50 g / L; the purification preferably comprises purification using a macroporous resin; the macroporous resin is preferably D101 macroporous resin; the step of purifying using a macroporous resin preferably comprises: eluting with pure water, 40% v / v ethanol and 80% v / v ethanol in sequence, using 4-6 column volumes for each eluent, collecting the 80% v / v ethanol eluent, concentrating, and drying to constant weight.
[0048] In the present invention, calculated on a dry basis, the total amount of cannabidiol and cannabidiol in the hemp extract is preferably 10 wt% to 60 wt%, more preferably 40 wt% to 60 wt%, and more preferably 60 wt%. The preparation method of the cloud hemp extract preferably comprises: mixing cloud hemp powder with 80%-95% v / v ethanol solution, soaking for 12-24 hours, heating and refluxing extraction at 80-90°C for 2-5 times, each time for 3-5 hours, combining the extracts, filtering under reduced pressure, concentrating, and drying to constant weight to obtain a cloud hemp crude extract; purifying the crude extract to obtain the cloud hemp extract; the solid-liquid ratio of the cloud hemp powder to ethanol is preferably 40-60 g / L, more preferably 50 g / L; the purification preferably comprises purification using a macroporous resin; the macroporous resin is preferably D101 macroporous resin; the step of purifying using a macroporous resin preferably comprises: eluting with pure water, 40% v / v ethanol and 80% v / v ethanol in sequence, using 4-6 column volumes for each eluent, collecting the 80% v / v ethanol eluent, concentrating, and drying to constant weight.
[0049] In the present invention, calculated on a dry basis, the total amount of (25R)-2α,3β-dihydroxy-5α-spirostan-9-ene-12-one-3-O-β-D-pyranoglucopyranosyl-(1→2)-[β-D-pyranoxylanosyl-(1→3)]-β-D-pyranoglucopyranosyl-(1→4)-β-D-galactopyranoside in the Hosta odorata root extract is preferably 1% to 10wt%, more preferably 3wt% to 10wt%, and more preferably 10wt%. The preparation method of the hosta root extract preferably comprises: mixing the hosta root powder with 80% to 95% v / v ethanol solution, soaking for 12 to 24 hours, heating and refluxing extraction at 80 to 90° C. for 2 to 5 times, each time for 3 to 5 hours, combining the extracts, filtering under reduced pressure, concentrating, and drying to constant weight to obtain a crude extract of the hosta root; purifying the crude extract to obtain the hosta root extract; the solid-liquid ratio of the hosta root powder to ethanol is preferably 40 g / L to 60 g / L, more preferably 50 g / L; the purification preferably comprises purification using a macroporous resin; the macroporous resin is preferably D101 macroporous resin; the step of purifying using a macroporous resin preferably comprises: eluting with pure water, 40% v / v ethanol and 80% v / v ethanol in sequence, using 4 to 6 column volumes for each eluent, collecting the 80% v / v ethanol eluent, concentrating, and drying to constant weight.
[0050] In the present invention, the content of CP4 in the Tiger Palm Grass extract is preferably 20wt% to 80wt%, more preferably 60wt% to 80wt%, and more preferably 80wt%, calculated on a dry basis. The preparation method of the Tiger Palm Grass extract preferably comprises: mixing Tiger Palm Grass powder with 80% to 95% v / v ethanol solution, soaking for 12 to 24 hours, heating and refluxing extraction at 80 to 90°C for 2 to 5 times, each time for 3 to 5 hours, combining the extracts, filtering under reduced pressure, concentrating, and drying to constant weight to obtain a crude Tiger Palm Grass extract; re-dissolving the crude Tiger Palm Grass extract in water, filtering, precipitating with hot acetone, and filtering again to obtain the Tiger Palm Grass extract; the solid-liquid ratio of the Tiger Palm Grass powder to ethanol is preferably 40 to 60g / L, and more preferably 50g / L.
[0051] The present invention can effectively control the quality of each extract by controlling the content of the antibacterial activity marker in each extract, thereby ensuring the stability of the antibacterial effect of the composition.
[0052] The present invention also provides the use of the antibacterial composition described in the above technical solution in the preparation of antibacterial products.
[0053] In the present invention, the antibacterial product preferably includes a product that inhibits the activity of pathogens; the pathogens preferably include bacteria and / or fungi, and the bacteria and / or fungi preferably include antibiotic-resistant bacteria and / or fungi; the bacteria are further preferably antibiotic-resistant bacteria, more preferably one or more of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), resistant Escherichia coli and resistant Acinetobacter baumannii; the fungi are preferably antibiotic-resistant fungi, more preferably fluconazole-resistant Candida albicans.
[0054] In the present invention, the dosage form of the product includes one or more of paste, cream, emulsion, gel, spray, aqueous solution, lotion, soap, ointment, suppository, capsule, powder, granule, tablet and effervescent agent. The antibacterial composition and antibacterial product provided by the present invention are suitable for preventing and treating skin and mucous membrane infections of humans and animals, covering various infections such as trauma, surgical trauma, reproductive tract, external genitalia, oral cavity, hands and feet. Specific application scope includes prevention and treatment of carbuncle, dermatitis, eczema, psoriasis, rosacea, athlete's foot, onychomycosis, bedsore, burn, scald, sunburn, trauma, mosquito bites, skin redness and swelling, stomatitis, vaginitis and similar diseases of animal skin and mucous membrane.
[0055] The present invention also provides an antibacterial cream, which comprises the following ingredients: 0.02wt% to 1wt% of the antibacterial composition described in the above technical scheme, 10wt% to 30wt% of glycerol, 4wt% to 10wt% of beeswax, 4wt% to 10wt% of liquid paraffin, 1wt% to 10wt% of octadecyl alcohol, 0.5wt% to 5wt% of hexadecanol, 1wt% to 10wt% of white vaseline, 1wt% to 8wt% of silicone oil, 0.2wt% to 5wt% of glyceryl monostearate, 1wt% to 6wt% of propylene glycol, 0.1wt% to 2wt% of Tween 80, 0.1wt% to 1wt% of triethanolamine, and the remainder of water and polyoxyethylene hydrogenated castor oil; the mass ratio of the polyoxyethylene hydrogenated castor oil to the antibacterial composition is 0.5 to 3:1. As a preferred embodiment of the present invention, the antibacterial cream comprises the following ingredients, measured by mass: 0.32wt% of an antibacterial composition, 16wt% of glycerol, 5wt% of beeswax, 5wt% of liquid paraffin, 4wt% of octadecyl alcohol, 2wt% of hexadecanol, 3wt% of white vaseline, 2wt% of silicone oil, 1wt% of glyceryl monostearate, 3wt% of propylene glycol, 0.8wt% of Tween 80, 0.4wt% of triethanolamine, 0.4wt% of polyoxyethylene hydrogenated castor oil, and the balance of water.
[0056] The present invention also provides an antibacterial cream, which comprises the following components in parts by mass: 0.02wt% to 1wt% of the antibacterial composition described in the above technical solution, 60wt% to 80wt% of white vaseline, 5wt% to 20wt% of glycerol, 1wt% to 10wt% of lanolin, 0.5wt% to 5wt% of liquid paraffin, 0.2wt% to 5wt% of glyceryl monostearate, 1wt% to 6wt% of propylene glycol, 0.1wt% to 2wt% of Tween 80, 0.0wt% to 0.5wt% of borneol, and the remainder of water and polyoxyethylene hydrogenated castor oil; the mass ratio of the polyoxyethylene hydrogenated castor oil to the composition is 0.5 to 3:1. As a preferred embodiment of the present invention, the antibacterial ointment comprises the following ingredients, measured in parts by mass: 0.32wt% of antibacterial composition, 74wt% of white vaseline, 14wt% of glycerol, 4wt% of lanolin, 2wt% of liquid paraffin, 2wt% of glyceryl monostearate, 2.28wt% of propylene glycol, 0.4wt% of polyoxyethylene hydrogenated castor oil, 0.8wt% of Tween 80, and 0.2wt% of borneol.
[0057] The antibacterial cream and antibacterial cream provided by the present invention have strong antibacterial activity against antibiotic-resistant bacteria, can be used to inhibit the proliferation of fungi or bacteria, and improve infection symptoms, while being non-irritating to the skin.
[0058] In the embodiments of the present invention, experiments were conducted using methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci, fluconazole-resistant Candida albicans, drug-resistant Escherichia coli and drug-resistant Acinetobacter baumannii as examples, but the composition provided by the present invention also has inhibitory and killing effects on other pathogenic bacteria and super-resistant bacteria.
[0059] In order to further illustrate the present invention, an antibacterial composition and its application provided by the present invention are described in detail below in conjunction with the accompanying drawings and examples, but they should not be construed as limiting the scope of protection of the present invention.
[0060] It should be emphasized that the following embodiments are only illustrative examples and do not limit the protection scope of the present invention, and the protection scope of the present invention shall be subject to the claims. Non-essential improvements and adjustments still fall within the protection scope of the present invention.
[0061] Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the technical field; the technical terms or scientific terms used should have the common meanings understood by technicians in the field to which the present invention belongs.
[0062] In the embodiment of the present invention, the medicinal materials of Morus alba bark, Hemp, Hosta odorata root and Herba Cynanchifoliae were purchased from Kunming medicinal materials market; and Hinokitiol was purchased from Tianjin Xiensi Biochemical Technology Co., Ltd.
[0063] Example 1
[0064] according to Figure 1 Preparation of Morus alba extract, Hemp extract, Hosta root extract and Tiger Palm extract
[0065] 1. Take 60g of dried mulberry bark, crush it into coarse powder, and put it into a round-bottom flask. Add 1200mL of 80% v / v ethanol solution, soak for 12h, heat and reflux at 80℃ for 3h, repeat the extraction three times, and combine the three extracts. Then, vacuum filter, concentrate and dry to constant weight to obtain 13.5g of mulberry bark crude extract. The obtained mulberry bark crude extract was further purified using D101 macroporous resin: eluted with pure water, 40% v / v ethanol and 80% v / v ethanol in sequence, and each eluent used 4 to 6 column volumes. Collect the 80% v / v ethanol eluent, concentrate and dry to constant weight to obtain 2.5g of mulberry bark extract (sbp), and the yield was statistically analyzed (Table 1).
[0066] 2. Take 60g of dried hemp, crush it into coarse powder, and put it into a round-bottom flask. Add 1200mL of 80% v / v ethanol solution, soak for 12h, heat and reflux at 80℃ for 3h, repeat the extraction three times, and combine the three extracts. Then, vacuum filter, concentrate and dry to constant weight to obtain 5.6g of hemp crude extract. The obtained hemp crude extract was further purified using D101 macroporous resin: eluted with pure water, 40% v / v ethanol and 80% v / v ethanol in turn, and each eluent used 4 to 6 column volumes. Collect the 80% v / v ethanol eluent, concentrate and dry to constant weight, and obtain 1.5g of hemp extract (ym), and the yield is statistically analyzed (Table 1).
[0067] 3. Take 60g of dried Hosta root, crush it into coarse powder, and put it into a round-bottom flask. Add 1200mL of 80% v / v ethanol solution, soak for 12h, and then reflux extract. Heat reflux extraction at 80℃ for 3h, repeat the extraction three times, and combine the three extracts. Then, vacuum filter, concentrate and dry to constant weight to obtain 17.4g of Hosta root crude extract. The obtained Hosta root crude extract was further purified using D101 macroporous resin: eluted with pure water, 40% v / v ethanol and 80% v / v ethanol in turn. Collect the 80% v / v ethanol eluate, concentrate and dry to constant weight, and obtain 1.4g of Hosta root extract (yzg), and the yield is statistically calculated (Table 1).
[0068] 4. Take 60g of dried tiger palm grass, crush it into coarse powder, and put it into a round-bottom flask. Add 1200mL of 80% v / v ethanol solution, soak for 12h, and then reflux extract. Heat reflux extraction at 80℃ for 3h, repeat the extraction three times, and combine the three extracts. Then reduce the pressure and filter, concentrate and dry to constant weight to obtain 13.2g of tiger palm grass crude extract. The prepared tiger palm grass crude extract was re-dissolved in water and the precipitate was filtered; the precipitate was precipitated with hot acetone, and crude crystals were obtained after filtration, and 8.8g of the tiger palm grass extract (hzc) was obtained, and the yield was statistically analyzed (Table 1).
[0069] Table 1 Yield of antibacterial extracts (dry weight)
[0070] Extract Name abbreviation Crude extract yield Extract yield Morus alba extract sbp 22.5% 4.2% Cloud hemp extract ym 9.3% 2.5% Hosta Root Extract yzg 29.0% 2.3% Tiger Palm Extract hz 22.0% 14.7%
[0071] Example 2
[0072] Detection of active biomarkers in extracts
[0073] The antibacterial activity markers in the four extracts obtained in Example 1 were qualitatively and quantitatively analyzed by LC-MS technology.
[0074] Detection method: The extract samples and standards were dissolved in methanol (mass spectrometry grade, Merck) and filtered through a 0.22 μm organic membrane. Data were collected using an Agilent 1290 Infinity II ultra-high performance liquid chromatograph and a G6545B quadrupole-time-of-flight tandem mass spectrometer (Agilent Technologies, Santa Clara, CA, USA). The extract was separated using an Agilent SB C18 reverse phase column (2.1 mm × 100 mm, 1.8 μm, Agilent Technologies). The column temperature was set at 35 °C, the mobile phase was 0.1% formic acid water (phase A) and pure acetonitrile (phase B), and the gradient elution flow rate was 0.15 mL / min. The optimized elution program was as follows: 0-2 min, 20%-40% B; 2-15 min, 40%-60% B; 15-20 min, 60%-70% B; 20-40 min, 70%-90% B; 40-45 min, 90%-95% B. Data were collected in ESI positive and negative ion modes.
[0075] The compound identification was performed by comparing the mass spectral data of the compound with the corresponding standard and the mass spectral data reported in the literature. The structural formula of each compound is as follows Figure 2 The identified compounds were quantitatively analyzed using a standard curve, where diosgenin was used to replace the active compounds in the root of Hosta odorata. The results are shown in Tables 2 and Figure 3 .
[0076] Table 2 Qualitative and quantitative analysis results of antibacterial activity markers in extracts
[0077]
[0078]
[0079] The numbers in the table correspond to Figure 2 and Figure 3 The number in .
[0080] From Table 2 and Figure 3It can be seen that the main antibacterial activity markers of each extract are as follows: the extract of Morus alba is mainly flavonoids, represented by Morusin, Kuwanon G and Kuwanon H; the extract of Hemp is mainly cannabinoids, represented by Cannabidiol and Cannabidivarin; the extract of Hosta odorata root is mainly saponin, represented by (25R)-2α,3β-dihydroxy-5α-spirostan-9-ene-12-one-3-O-β-D-pyranoglucopyranosyl-(1→2)-[β-D-pyranosyl-(1→3)]-β-D-pyranoglucopyranosyl-(1→4)-β-D-galactopyranoside (hereinafter referred to as Q-Marker 6); the extract of Herba Sativae is mainly saponin, represented by prosapogenin CP4 ( CP4) is represented.
[0081] Example 3
[0082] Antibacterial activity detection of extracts and their antibacterial activity markers
[0083] The minimum inhibitory concentration (MIC value) and the inhibition curve were used as the main indicators to detect and evaluate the antibacterial activity of the extract prepared in Example 1 and the active marker detected in Example 2.
[0084] (1) MIC value detection method: Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), fluconazole-resistant Candida albicans (C.albicans), drug-resistant Escherichia coli (E.coli) and drug-resistant Acinetobacter baumannii (A.baumannii) were cultured in tryptic soy broth (TSB) until the exponential phase, and the bacterial concentration was adjusted to about 5×10 5 CFU / mL, and prepare the corresponding 5 kinds of microbial suspensions. Prepare samples or antibiotics in 96-well plates using the two-fold dilution method, incubate at 37°C for 24 hours, and then use an ELISA reader to measure OD 600 The MIC value was determined by measuring the nm value. The experiment was repeated three times independently with a control group. The test results are shown in Table 3.
[0085] (2) Inhibition curve test method: The above five microbial suspensions were mixed with test samples at 1 / 4 and 1 / 2 MIC concentrations, mixed with positive antibiotics at 1 / 2 MIC, and incubated with blank solvent as a control group (Control) at 37°C. The OD of each sample was measured using an ELISA reader at 0 h, 2 h, 4 h, 6 h, 8 h, 12 h, 16 h, 20 h, and 24 h of incubation. 600nmThe results were repeated three times independently to show the effect of the extract on the growth of microorganisms. Figure 4 shown.
[0086] Table 3 MIC values of extracts and their active markers (μg / mL)
[0087]
[0088] Among them, a represents positive drug; b represents negative drug; NT represents not tested. As shown in Table 3, the extracts of Morus alba and Yunma have significant anti-MRSA and VRE activity, with MIC of 4-8μg / mL; the extracts of Hosta odorata root and Tiger palm grass have significant anti-C.albicans activity, with MIC of 16μg / mL; Hinokitiol has significant anti-C.albicans, E.coli and A.baumannii activity, with MIC of 4-32μg / mL; at the same time, the active markers in the extracts show good antibacterial activity, with MIC of 2-16μg / mL, which is the material basis of the antibacterial activity of the extracts.
[0089] Embodiment 4 to Embodiment 11
[0090] Preparation of antibacterial composition and detection of its antibacterial activity
[0091] The antibacterial composition was prepared according to the formula described in Table 4.
[0092] Table 4 Composition of components of Examples 4 to 11
[0093]
[0094] The antibacterial activity of the compositions described in the above 8 examples was tested according to the method described in Example 3, and the added concentration (MIC) of each composition in the bacterial solution is shown in Table 5. The results are shown in Table 5 and Figures 4 to 11 shown.
[0095] Table 5 MIC and interaction relationship of each antibacterial composition
[0096]
[0097] NT means not tested.
[0098] According to the antibacterial test results in Table 5, the compositions of Example 4, Example 5, Example 10 and Example 11 showed synergistic effects on MRSA, while the compositions of Example 5, Example 10 and Example 11 also showed synergistic effects on VRE. That is, the extract of Hosta odorata root and the extract of Herba Sativae enhanced the antibacterial activity of the extract of Morus alba against MRSA; at the same time, the addition of hinokitiol improved the antibacterial activity of the compositions of Example 6 and Example 7 against MRSA and VRE.
[0099] Figures 4 to 11 The results of the antibacterial test show that the composition of the present invention has good antibacterial activity. At a concentration of 1 / 2MIC, the anti-MRSA activities of the extracts of Morus alba and Yunmai, the anti-fluconazole-resistant Candida albicans activities of the root extract of Hosta odorata, and the anti-resistant Acinetobacter baumannii and resistant Escherichia coli of hinokitiol are better than those of positive antibiotics. Specifically, the antibacterial activities of the compositions of Examples 4 to 11 against MRSA are better than those of vancomycin; the antibacterial activities of the compositions of Examples 5, 10 and 11 against VRE exceed those of meropenem; and the antibacterial activities of the compositions of Examples 8, 9, 10 and 11 against resistant Acinetobacter baumannii are better than those of cefoperazone.
[0100] Example 12
[0101] Preparation of antibacterial cream based on Example 8
[0102] The raw materials for making the antibacterial cream are shown in Table 6.
[0103] Table 6 Composition and content of antibacterial cream
[0104]
[0105] The production steps are as follows:
[0106] (1) Phase A: According to the amounts listed in Table 6, weigh the components of Phase A into an emulsifier. Set the heating temperature to 80°C and heat while stirring until the oil phase melts. Then lower the temperature to 60°C and keep warm for later use.
[0107] (2) Phase B: Weigh the ingredients in composition 5 (mulberry bark extract, hosta root extract, and hinokitiol) according to the amounts listed in Table 6, and add polyoxyethylene hydrogenated castor oil. Stir and mix at 50°C to fully mix the composition and polyoxyethylene hydrogenated castor oil, and then add propylene glycol. Continue stirring to fully dissolve the composition in propylene glycol, then add Tween 80, stir and mix, and keep warm for later use.
[0108] (3) Phase C: Weigh propylene glycol, triethanolamine, benzyl alcohol and purified water, heat to 60°C, stir to mix, and keep warm for later use.
[0109] (4) Mixing: Slowly pump phase B into the emulsifier and mix with phase A. Then pump phase C into the emulsifier and mix again. If necessary, vacuum degassing can be performed to remove bubbles. Stop stirring after the mixture temperature drops to room temperature and dispense.
[0110] Example 13
[0111] Preparation of antibacterial cream based on Example 9
[0112] The raw materials for making the antibacterial ointment are shown in Table 7.
[0113] Table 7 Ingredients and contents of antibacterial cream
[0114]
[0115] The production steps are as follows:
[0116] (1) Phase A: According to the amounts recorded in Table 7, weigh the components of Phase A into an oil pan. Set the heating temperature to 80°C and heat while stirring until the oil phase melts and the matrix becomes clear and transparent. Then reduce the temperature to 60°C and keep warm for later use.
[0117] (2) Phase B: According to the amounts recorded in Table 7, weigh the components of composition 6 (mulberry bark extract, tiger palm grass extract and hinokitiol), and add polyoxyethylene hydrogenated castor oil. Stir and mix at 50°C to fully mix the composition and polyoxyethylene hydrogenated castor oil. Then continue to add propylene glycol and stir to fully dissolve the composition in propylene glycol, then add borneol and Tween 80, and continue stirring until the borneol is completely dissolved to ensure that the entire system is mixed evenly. Keep the temperature at 50°C and set aside.
[0118] (3) Mixing: Slowly pour the mixed phase B into phase A and stir evenly. If necessary, vacuum degassing can be performed to remove bubbles. After mixing evenly, keep the temperature at 60°C for packaging, and then cool to room temperature to obtain the product.
[0119] Embodiment 14
[0120] Bactericidal and antibacterial properties testing of antibacterial creams and antibacterial ointments
[0121] The antibacterial cream prepared in Example 12 and the antibacterial cream prepared in Example 13 were used as test samples to detect their antibacterial properties against Staphylococcus aureus, Escherichia coli, Candida albicans, methicillin-resistant Staphylococcus aureus and drug-resistant Acinetobacter baumannii. The detection method refers to WS / T 650-2019 "Antibacterial and Antibacterial Effect Evaluation Method" 5.2.2.5 and 2.1.1.5; the test results are shown in Tables 8 and 9.
[0122] Table 8 Antibacterial cream bactericidal test effect
[0123] Bacteria Inhibition rate after 5.0 min of action (%) Positive control colony count (mean) Staphylococcus aureus 93.69 <![CDATA[3.71×10 4 ]]> Escherichia coli 94.64 <![CDATA[6.16×10 4 ]]> Candida albicans 90.23 <![CDATA[3.07×10 4 ]]> Methicillin-resistant Staphylococcus aureus 93.82 <![CDATA[3.67×10 4 ]]> Drug-resistant Acinetobacter baumannii 94.04 <![CDATA[3.51×10 4 ]]>
[0124] The antibacterial rate is the average of three repeated tests; the negative control has no bacterial growth.
[0125] Table 9 Antibacterial ointment antibacterial test effect
[0126] Bacteria Inhibition rate after 5.0 min of action (%) Positive control colony count (mean) Staphylococcus aureus 99.95 <![CDATA[8.37×10 4 ]]> Escherichia coli 99.98 <![CDATA[8.18×10 4 ]]> Candida albicans 99.67 <![CDATA[8.12×10 4 ]]> Methicillin-resistant Staphylococcus aureus 99.97 <![CDATA[7.55×10 4 ]]> Drug-resistant Acinetobacter baumannii 99.96 <![CDATA[8.05×10 4 ]]>
[0127] The antibacterial rate is the average of three repeated tests; the negative control has no bacterial growth.
[0128] It can be seen from Tables 8 and 9 that after the antibacterial cream provided in Example 12 was applied for 5.0 minutes, the bactericidal rate of the above five bacteria was greater than 90%, and it had an antibacterial effect, which complies with the provisions of WS / T 650-2019 "Antibacterial and Antibacterial Effect Evaluation Method". After the antibacterial cream provided in Example 13 was applied for 5.0 minutes, the bacteriostatic rate of the above five bacteria was greater than 90%, and it had a strong antibacterial effect. It complies with the provisions of WS / T 650-2019 "Antibacterial and Antibacterial Effect Evaluation Method".
[0129] Embodiment 15
[0130] The antibacterial cream prepared in Example 12 and the antibacterial cream prepared in Example 13 were used as test samples, and multiple complete skin irritation tests were carried out on Japanese big-eared rabbits. The detection method was based on Item 2.3.3.3.3 of the Technical Specification for Disinfection (2002 edition). The test results are shown in Tables 10 and 11.
[0131] Table 10 Scoring results of multiple complete skin irritation reactions of the antibacterial cream of Example 5
[0132]
[0133]
[0134] Table 11 Scoring results of multiple complete skin irritation reactions of the antibacterial cream of Example 6
[0135]
[0136] As shown in Table 10 and Table 11, the total integral average values (irritation index) of the multiple complete skin irritation tests of the antibacterial cream prepared in Example 12 and the antibacterial cream prepared in Example 13 are both 0.00 (0—<0.5), and the irritation intensity is non-irritating, which meets the requirements of the "Technical Specifications for Disinfection" (2002 Edition).
[0137] It can be seen from the above examples that the antibacterial composition provided by the present invention has a good inhibitory effect on methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), fluconazole-resistant Candida albicans, resistant Escherichia coli and resistant Acinetobacter baumannii. The antibacterial cream and antibacterial ointment prepared based on the antibacterial composition have strong antibacterial activity against antibiotic-resistant bacteria, can be used to inhibit the proliferation of fungi or bacteria, and improve infection symptoms, and are non-irritating to the skin.
[0138] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.
Claims
1. An antibacterial composition, characterized in that The antibacterial composition comprises a first component, a second component and a third component; The first component includes hinokitiol; The second component includes Morus alba bark extract and / or Hemp extract; The third component includes Hosta odorata root extract and / or Herba Lycopodii extract.
2. The antibacterial composition according to claim 1, characterized in that In the antibacterial composition, the concentration of the first component is ≥32 μg / mL; the concentration of the second component is ≥4 μg / mL; and the concentration of the third component is ≥16 μg / mL.
3. The antibacterial composition according to claim 1, characterized in that Calculated on the basis of the dry product content, the total amount of mulberry flavonoids, mulberry flavonoids G and mulberry flavonoids H in the mulberry bark extract is 10wt% to 60wt%; In the hemp extract, the total amount of cannabidiol and cannabidiol is 10wt% to 60wt%; In the hosta root extract, the total amount of (25R)-2α,3β-dihydroxy-5α-spirostan-9-ene-12-one-3-O-β-D-pyranoglucopyranosyl-(1→2)-[β-D-pyranoxylanosyl-(1→3)]-β-D-pyranoglucopyranosyl-(1→4)-β-D-galactopyranoside is 1wt% to 10wt%; In the Herba Lycopodii extract, the content of prosapogenin CP4 is 20wt% to 80wt%.
4. The antibacterial composition according to claim 1, characterized in that The preparation method of the mulberry bark extract comprises: mixing mulberry bark powder with 80% to 95% v / v ethanol solution, soaking for 12 to 24 hours, heating and refluxing extraction at 80 to 90° C. for 2 to 5 times, each time for 3 to 5 hours, combining the extracts, filtering under reduced pressure, concentrating, and drying to constant weight to obtain a mulberry bark crude extract; purifying the crude extract to obtain a mulberry bark extract; The preparation method of the cloud hemp extract comprises: mixing cloud hemp powder with 80% to 95% v / v ethanol solution, soaking for 12 to 24 hours, heating and refluxing extraction at 80 to 90° C. for 2 to 5 times, each time for 3 to 5 hours, combining the extracts, filtering under reduced pressure, concentrating, and drying to constant weight to obtain a cloud hemp crude extract; purifying the cloud hemp crude extract to obtain the cloud hemp extract; The preparation method of the hosta root extract comprises: mixing the hosta root powder with 80% to 95% v / v ethanol solution, soaking for 12 to 24 hours, heating and refluxing extraction at 80 to 90° C. for 2 to 5 times, each time for 3 to 5 hours, combining the extracts, filtering under reduced pressure, concentrating, and drying to constant weight to obtain a crude hosta root extract; purifying the crude hosta extract to obtain the hosta root extract; The preparation method of the tiger palm grass extract comprises: mixing tiger palm grass powder with 80% to 95% v / v ethanol solution, soaking for 12 to 24 hours, heating and refluxing extraction at 80 to 90° C. for 2 to 5 times, each time for 3 to 5 hours, combining the extracts, filtering under reduced pressure, concentrating, and drying to constant weight to obtain a crude tiger palm grass extract; adding water to re-dissolve the crude tiger palm grass extract, filtering, precipitating with hot acetone, and filtering again to obtain the tiger palm grass extract; The solid-liquid ratio of the mulberry bark powder to the 80%-95% v / v ethanol solution is 40-60 g / L; the solid-liquid ratio of the cloud hemp powder to the 80%-95% v / v ethanol solution is 40-60 g / L; the solid-liquid ratio of the hosta root powder to the 80%-95% v / v ethanol solution is 40-60 g / L; the solid-liquid ratio of the tiger palm powder to the 80%-95% v / v ethanol solution is 40-60 g / L.
5. The antibacterial composition according to claim 4, characterized in that The purification includes purification using a macroporous resin.
6. Use of the antibacterial composition according to any one of claims 1 to 5 in the preparation of an antibacterial product.
7. The use according to claim 6, characterized in that: The antibacterial products include products that inhibit the activity of pathogenic bacteria; the pathogenic bacteria include bacteria and / or fungi, and the bacteria and / or fungi include antibiotic-resistant bacteria and / or fungi.
8. The use according to claim 6 or 7, characterized in that: The dosage form of the product includes one or more of paste, cream, emulsion, gel, spray, aqueous solution, lotion, soap, ointment, suppository, capsule, powder, granule, tablet and effervescent.
9. An antibacterial cream, characterized in that: The antibacterial cream comprises the following ingredients: 0.02wt% to 1wt% of the antibacterial composition according to any one of claims 1 to 5, 10wt% to 30wt% of glycerol, 4wt% to 10wt% of beeswax, 4wt% to 10wt% of liquid paraffin, 1wt% to 10wt% of octadecyl alcohol, 0.5wt% to 5wt% of hexadecanol, 1wt% to 10wt% of white vaseline, 1wt% to 8wt% of silicone oil, 0.2%wt to 5wt% of glyceryl monostearate, 1wt% to 6wt% of propylene glycol, 0.1wt% to 2wt% of Tween 80, 0.1wt% to 1wt% of triethanolamine, and the remainder of water and polyoxyethylene hydrogenated castor oil; The mass ratio of the polyoxyethylene hydrogenated castor oil to the antibacterial composition is 0.5-3:
1.
10. An antibacterial cream, characterized in that: The antibacterial cream comprises the following ingredients: 0.02wt% to 1wt% of the antibacterial composition according to any one of claims 1 to 5, 60wt% to 80wt% of white vaseline, 5wt% to 20wt% of glycerol, 1wt% to 10wt% of lanolin, 0.5wt% to 5wt% of liquid paraffin, 0.2wt% to 5wt% of glyceryl monostearate, 1wt% to 6wt% of propylene glycol, 0.1wt% to 2wt% of Tween 80, 0.0wt% to 0.5wt% of borneol, and the remainder of water and polyoxyethylene hydrogenated castor oil; The mass ratio of the polyoxyethylene hydrogenated castor oil to the antibacterial composition is 0.5-3:1.
Citation Information
Patent Citations
Preparation method and application of hosta plantaginea root animal-origin-fungi-resistant effective parts
CN110538263A
Application of hinokitiol composition in preparation of staphylococcus aureus inhibitor
CN116236466A
Cited By
Screening method and application of carbapenem-resistant klebsiella pneumoniae traditional Chinese medicine inhibitor
CN121496038A
